Strong positive interim data from an earlier Phase 3 trial has led to early cessation of Merck’s pulmonary arterial ...
MedPage Today on MSN4d
Sotatercept Helps the Sickest Patients With Pulmonary Arterial HypertensionCHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...
News-Medical.Net on MSN11d
Blocking Piezo2 may offer a new therapeutic approach for pulmonary fibrotic diseasesResearchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback